Baker Hughes is in a broad recovery uptrend that has stalled in recent months, with the stock up 25.74% over the past year and 25.29% year-to-date, though it has pulled back to $59.06 from its 52-week high of $70.41. At the current price, BKR is trading at approximately 57% of its 52-week range (calculated as ($59.06 - $43.92) / ($70.41 - $43.92)), positioning it in the middle-upper portion of its annual band — not extended near highs, but well above the lows, suggesting a consolidating uptrend rather than a momentum breakout or a falling knife. The 52-week low of $43.92 implies roughly 26% downside to the floor, while the high of $70.41 implies about 19% upside to the ceiling, framing a roughly balanced risk-reward within the established range. Short-term momentum has deteriorated sharply and diverges from the longer-term trend: the stock is down 8.12% over the past month and 6.46% over three months, even as it remains up 8.85% over six months and 25.74% over a year. This divergence — positive 1-year but negative 1-month and 3-month — signals a meaningful correction within an intact uptrend, and the relative strength figures confirm the underperformance: BKR trails SPY by 7.06 percentage points over one month and 9.50 points over three months, despite outperforming by 9.52 points over one year. The recent slide from $63.64 on September 9 to $59.06 on September 11 (a roughly 7% two-day drop) on elevated volume of 10.19 million shares suggests distribution pressure that warrants caution until price stabilizes. Key technical levels are clearly defined: support sits at the 52-week low of $43.92, with intermediate support likely near the July trough around $52.78, while resistance is anchored at the 52-week high of $70.41, with the recent $64.90 area (August highs) acting as nearer-term overhead supply. A breakout above $70.41 would confirm trend resumption and likely open a new leg higher, whereas a breakdown below the $52.78 July low would threaten the recovery structure and put the $43.92 floor in play. With a beta of 0.961, BKR is slightly less volatile than the broader market — roughly 4% less volatile than SPY — meaning position sizing can be somewhat more aggressive than for a high-beta energy name, though the 24.24% max drawdown underscores that this is still a cyclical stock capable of sharp reversals.

Baker Hughes' revenue trajectory is modestly growing but decelerating, with Q1 2026 revenue of $6.587 billion representing 2.49% year-over-year growth versus Q1 2025's $6.427 billion. The multi-quarter trend shows sequential softness: revenue declined from $7.386 billion in Q4 2025 to $7.010 billion in Q3 2025 to $6.587 billion in Q1 2026, reflecting the seasonal Q1 dip and a tougher demand backdrop. Segment data shows a near-even split between Industrial and Energy Technology at $3.35 billion and Oilfield Services and Equipment at $3.237 billion, meaning the industrial side is now the larger contributor — a notable shift that provides diversification but also exposes the company to industrial capex cycles rather than pure upstream oil and gas spending. The growth rate in the low single digits implies a mature, cash-generative business rather than a high-growth story, making margin expansion and capital returns the primary value drivers. Profitability is solid and improving: Q1 2026 net income was $930 million on a 14.12% net margin, up from $402 million and a 6.25% net margin in Q1 2025, a dramatic year-over-year improvement. Gross margin came in at 22.83% in Q1 2026, slightly below the 23.73% in Q4 2025 but above the 22.95% in Q1 2025, while operating margin of 12.28% and EBITDA of $1.714 billion (26.02% EBITDA margin) reflect healthy operating leverage. The trailing net margin of 9.33% and operating margin of 12.83% are consistent with the capital-intensive oilfield services industry, where mid-teens operating margins are competitive; the improvement in net income despite flat revenue signals effective cost control and a favorable mix shift. The balance sheet is conservatively managed with a debt-to-equity ratio of just 0.379 and a current ratio of 1.357, indicating ample liquidity and modest leverage. Free cash flow on a trailing basis is $2.292 billion, though Q1 2026 free cash flow was only $164 million (operating cash flow of $500 million less $336 million capex), a seasonal low that reflects working capital swings. ROE of 13.74% and ROA of 4.85% are respectable for the sector, and the company returned capital via $228 million in dividends in Q1 2026 while maintaining a payout ratio of 35.16% and a dividend yield of 2.02%. The Q1 2026 cash flow statement shows a large $9.885 billion debt repayment alongside $13.81 billion in acquisition inflows and a $11.049 billion net change in cash, ending with $14.764 billion in cash — a liquidity position that provides substantial flexibility for future M&A, buybacks, or debt reduction.